Fostering the development of AI-enhanced technologies to support healthy aging at home for older adults and individuals with Alzheimer’s disease.
Neuroimmune Foundation Models for Uncovering Biomarkers in Alzheimer’s Disease and Related Dementias
Investigators:
Mariano I. Gabitto, Allen Institute
Using AI to Repurpose Small Molecules to Target Amyloid-tau Interactions in AD
Investigators:
Jeremy Linsley, Operant BioPharma
Voiceitt: AI-Enabled Speech Recognition for Older Adults with Severe Dysarthria
Investigators:
Katie Seaver, The Babel Group
Rachel Levy, The Babel Group
